TNFAIP3 and marginal zone lymphoma: In addition to chromosomal translocation, TNFAIP3, a negative regulator of the NF-κB pathway, was found to be inactivated via somatic deletion and/or mutation in ocular MZL in 12-37% of ocular MZL cases [4].